🇺🇸 FDA
Patent

US 6056952

Selective elimination of T cells that recognize specific preselected targets

expired A61KA61K2035/122A61K2035/124

Quick answer

US patent 6056952 (Selective elimination of T cells that recognize specific preselected targets) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2035/122, A61K2035/124, A61K2239/38, A61K35/00